Group 1 - The survival time of prostate cancer patients is closely related to the clinical stage of malignancy at diagnosis [1][2] - Prostate cancer is the second most common malignancy and the fifth leading cause of cancer death among men globally, with significant prevalence in Europe and the United States [1] - The incidence and mortality rates of prostate cancer in China account for 8.2% and 13.6% of the global figures, respectively, indicating a growing public health issue [2] Group 2 - Early detection and timely surgical treatment can lead to complete cure of prostate cancer, emphasizing the importance of early diagnosis [2][3] - The overall prognosis for prostate cancer patients in China is poor, with only 30% of initial cases being clinically localized, compared to higher survival rates in developed countries [2] - The 5-year survival rate for localized prostate cancer in the U.S. is nearly 100%, while it drops to 30% for metastatic cases [2] Group 3 - There is a significant challenge in prostate cancer screening due to insufficient awareness among government, healthcare providers, and the public [3] - The lack of standardized screening protocols and low public awareness hinder effective early diagnosis and treatment of prostate cancer in China [3] - The recommendation for routine PSA testing for men over 50 is not widely implemented, leading to late-stage diagnoses [3]

Core Insights - Prostate cancer, often referred to as "retirement cancer," poses a significant health threat to older men globally, with rising incidence and mortality rates necessitating increased public awareness and standardized treatment protocols [1][2] Group 1: Awareness and Education Initiatives - The Beijing Integrative Medicine Association has launched a health education project for prostate cancer patients, aiming to enhance knowledge about the disease and treatment options through online and offline meetings [1] - During the National Cancer Week from April 15-21, a health education event was held by the Urology Department of Beijing Hospital, emphasizing the importance of early screening for prostate cancer [1] Group 2: Screening and Diagnosis - Early detection is crucial, as prostate cancer often progresses slowly, leading to late diagnoses when symptoms become apparent [2][3] - The prostate-specific antigen (PSA) test is an effective and affordable screening method, yet many elderly men have not undergone this test [3] - Recommendations suggest that men over 50 should have regular PSA screenings, with follow-up procedures based on PSA levels [3][4] Group 3: Treatment Approaches - The survival rate for prostate cancer patients is closely linked to the cancer stage at diagnosis, with early-stage patients having a higher likelihood of being cured through radical surgery or radiation [6] - For high-risk patients without metastasis, hormonal therapy may be used to shrink tumors before curative treatments [6] - Ongoing management and follow-up are essential in the treatment of prostate cancer to assess effectiveness and prevent treatment discontinuation [6]